Spire Wealth Management Buys 125 Shares of Leidos Holdings, Inc. (NYSE:LDOS)

Spire Wealth Management increased its stake in Leidos Holdings, Inc. (NYSE:LDOS) by 2.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 5,756 shares of the aerospace company’s stock after purchasing an additional 125 shares during the quarter. Spire Wealth Management’s holdings in Leidos were worth $632,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of LDOS. Raymond James Financial Services Advisors Inc. lifted its holdings in Leidos by 1.5% during the third quarter. Raymond James Financial Services Advisors Inc. now owns 13,101 shares of the aerospace company’s stock valued at $1,207,000 after purchasing an additional 194 shares during the last quarter. Mackenzie Financial Corp boosted its holdings in Leidos by 3.8% in the 3rd quarter. Mackenzie Financial Corp now owns 10,709 shares of the aerospace company’s stock worth $992,000 after buying an additional 390 shares during the period. IFM Investors Pty Ltd grew its stake in Leidos by 5.3% in the 3rd quarter. IFM Investors Pty Ltd now owns 12,727 shares of the aerospace company’s stock valued at $1,173,000 after buying an additional 637 shares in the last quarter. Advisor Partners II LLC raised its holdings in Leidos by 19.5% during the 3rd quarter. Advisor Partners II LLC now owns 5,741 shares of the aerospace company’s stock valued at $529,000 after acquiring an additional 938 shares during the period. Finally, Park Avenue Securities LLC purchased a new stake in shares of Leidos during the third quarter worth $237,000. 76.12% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Leidos news, Director Gary Stephen May sold 2,745 shares of the business’s stock in a transaction on Wednesday, February 21st. The stock was sold at an average price of $124.49, for a total value of $341,725.05. Following the sale, the director now directly owns 11,352 shares of the company’s stock, valued at $1,413,210.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Leidos news, Director Gary Stephen May sold 2,745 shares of the firm’s stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $124.49, for a total transaction of $341,725.05. Following the completion of the sale, the director now directly owns 11,352 shares in the company, valued at approximately $1,413,210.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director David G. Fubini sold 7,874 shares of the stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $127.89, for a total transaction of $1,007,005.86. Following the sale, the director now owns 14,696 shares in the company, valued at approximately $1,879,471.44. The disclosure for this sale can be found here. 0.96% of the stock is currently owned by company insiders.

Leidos Price Performance

Shares of NYSE LDOS opened at $146.83 on Friday. The company’s 50-day moving average is $130.54 and its 200 day moving average is $116.65. The company has a debt-to-equity ratio of 1.07, a current ratio of 1.35 and a quick ratio of 1.24. The stock has a market capitalization of $19.85 billion, a P/E ratio of 63.29, a P/E/G ratio of 1.82 and a beta of 0.66. Leidos Holdings, Inc. has a 1 year low of $76.58 and a 1 year high of $147.00.

Leidos (NYSE:LDOS) last released its quarterly earnings results on Tuesday, April 30th. The aerospace company reported $2.29 earnings per share for the quarter, beating the consensus estimate of $1.70 by $0.59. The company had revenue of $3.98 billion for the quarter, compared to analyst estimates of $3.82 billion. Leidos had a return on equity of 25.66% and a net margin of 2.04%. The firm’s revenue was up 7.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.47 earnings per share. On average, sell-side analysts expect that Leidos Holdings, Inc. will post 8.36 earnings per share for the current year.

Leidos Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, May 28th. Stockholders of record on Tuesday, May 14th will be issued a dividend of $0.38 per share. The ex-dividend date is Friday, June 14th. This represents a $1.52 annualized dividend and a dividend yield of 1.04%. Leidos’s payout ratio is 65.52%.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Robert W. Baird boosted their price objective on Leidos from $145.00 to $180.00 and gave the company an “outperform” rating in a research note on Wednesday, May 1st. Bank of America increased their price objective on Leidos from $125.00 to $145.00 and gave the stock a “buy” rating in a research report on Wednesday, March 27th. Jefferies Financial Group upped their target price on Leidos from $130.00 to $135.00 and gave the stock a “hold” rating in a research note on Wednesday, April 10th. Wells Fargo & Company boosted their price objective on Leidos from $137.00 to $147.00 and gave the stock an “overweight” rating in a report on Thursday, April 4th. Finally, Stifel Nicolaus raised their target price on shares of Leidos from $138.00 to $160.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Two research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $145.67.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.